SecBot SecBot
8-K ·Filed May 29, 2026

STSSW

SkyAI, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed5mo ago SEC0001493152-26-026381
8-K Item 1.01 + 5.02 (likely routine officer/director compensation agreement)
Actionable Insight • Neutral

This is a routine executive appointment with no immediate trading implications. Monitor future filings for any material agreements or changes in financial strategy that the new CFO may implement.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d
STSSW ▲ 0.00% at T+20d
NEUTRAL call 0.00% · α vs SPY +1.30% · entry $0.0329 → $0.0329
Next anchor: T+60d due 2mo ago
Entry = T+0 close
May 29, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.14%
$0.0329
settled 5mo ago
T+5d
0.00%
call 0.00% · α +2.75%
$0.0329
settled 5mo ago
T+20d
0.00%
call 0.00% · α +1.30%
$0.0329
settled 4mo ago
T+60d
Pending
due 2mo ago

Price Chart

Loading chart...

Executive Summary

SkyAI, Inc. (fka Sharps Technology) filed an 8-K formalizing the appointment of Arthur Levine as permanent CFO, converting his interim role (held since February 2026) into a three-year employment agreement with a $400,000 base salary, 50% annual bonus potential, and severance provisions. The filing is a routine executive appointment with no material financial data or strategic changes — it does not alter the company's operational outlook or capital structure.

Key Facts

  • Arthur Levine appointed permanent CFO effective May 22, 2026, after serving as interim CFO since February 2026.
  • Employment agreement provides $400,000 annual base salary, 50% of base salary annual cash bonus target, and eligibility for equity grants.
  • Severance: 1x base salary (non-CIC) or 3x base salary (CIC) plus equity acceleration, subject to release.
  • Agreement includes 18-month post-termination non-compete and non-solicitation covenants.
  • No material financial data, M&A, or operational changes disclosed in the filing.

Financial Impact

No material financial impact — the CFO salary of $400,000 is a routine operating expense for a public company.

operating expenses

Risk Factors

  • No financial or operational risks identified from this filing alone.

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001493152-26-026381
Document: form8-k.htm0001493152-26-026381
Document: 0001493152-26-026381-index-headers.html0001493152-26-026381
Document: 0001493152-26-026381-index.html0001493152-26-026381
Document: 0001493152-26-026381.txt0001493152-26-026381
2 reports for STSSW
Performance horizon
Filters
Rows
Reports for STSSW — sortable, filterable
TypeNow
Jun 1, 2026
21w ago
8-K
NEUTRAL ★ 4/10
$0.0329 $0.0329· 0.00%▲ +1.30%—
May 29, 2026
21w ago
8-K
NEUTRAL ★ 2/10
$0.0329 $0.0329· 0.00%▲ +1.30%—
Showing 2 of 2

US Market Status

Market Closed — Opens Wed (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 29, 2026